July 27, 2016 11:21 PM ET

Company Overview of Global Virus Network

Company Overview


United States

Key Executives for Global Virus Network

Co-Founder and Chair of Scientific Leadership Board
Age: 79
Senior Advisor
Age: 72
Compensation as of Fiscal Year 2016.

Global Virus Network Key Developments

The Global Virus Network Announces Executive Appointments

The Global Virus Network announced the appointment of José Esparza, MD, PhD as President of the company. Dr. Esparza’s appointment will boost company's global impact given his long career in global health, and in particular vaccine development, as evidenced by his successful leadership roles at the Bill & Melinda Gates Foundation. The company also announced the election of Raymond Schinazi, PhD, Hon DSc to company's executive committee. As company's President, Dr. Esparza’s priorities include growing company's funding base by linking governments, businesses, philanthropic organizations and other entities with interest in safeguarding the globe against existing and future viral threats. Dr. Esparza will also harness his expertise in science to initiate and strengthen international collaborations between top researchers in the company as well as to extend the company's reach to important regions of the world. Prior to joining the company as President, from 2004 to 2014 Dr. Esparza was with the Bill & Melinda Gates Foundation, first as Senior Advisor on HIV Vaccines and subsequently as Senior Advisor on Global Health (Vaccines). As a member of company's executive committee, Dr. Schinazi will provide invaluable council to ensure company's varying programs and initiatives continue to grow and succeed. Dr. Schinazi, who holds more than 90 issued U.S. and international patents.

Global Virus Network Announces Executive Changes

The Global Virus Network announced the election of finance and business leader N. Scott Fine as Chairman of the Board of Directors. Mr. Fine succeeds the outgoing Board Chairman, attorney Timothy C. Moynahan, who will take on a new role as Board Vice Chairman. In 2014, Mr. Fine was appointed Chairman of the Board of Directors of CTD Holdings Inc.

The Global Virus Network Announces Executive Changes

The Global Virus Network announced the election of Azad Moopen to it's board of directors. Dr. Moopen is an innovator in expanding access to healthcare. Dr. Azad Moopen is the chairman and managing director of Aster DM Healthcare. Joining GVN as a senior sdvisor is MV Pillai, MD, professor of Oncology at Thomas Jefferson University, Philadelphia and chairman of Oncology at Aster MedCity, among his other leadership roles.

Similar Private Companies By Industry

Company Name Region
Aryzta Us Holdings I Corp. United States
!SOLUTIONS! Group United States
"Atlantic Tele-Satellite, Inc. United States
"D" Construction, Inc. United States
"Graham & Associates,Inc" United States

Recent Private Companies Transactions

No transactions available in the past 12 months.

The information and data displayed in this profile are created and managed by Capital IQ, a Standard & Poor's company. Bloomberg.com does not create or control the content. For inquiries, please contact Capital IQ directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
Bloomberg L.P. United States
NYC2012, Inc. United States
Rush University United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Global Virus Network, please visit www.gvn.org. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.